Quick commerce startup Plazza has secured $15 million in a Series A round led by Accel, Elevation Capital, and Nexus Venture Partners. The company plans to use the capital to scale its AI-driven inventory network and shorten medicine delivery times. This funding arrives as competition in the rapid delivery space intensifies from major players like Flipkart and Zepto.
Pharmacy-focused quick commerce startup Plazza has raised $15 million in its Series A funding round. The investment was co-led by Accel, Elevation Capital, and Nexus Venture Partners, with additional participation from existing investors All In Capital and Better Capital. This fresh capital follows a seed round of $1.4 million and indicates continued backing for the company's model of rapid pharmaceutical fulfillment.
Plazza, based in Bengaluru and established in 2024 by founder Aman Priyadarshi, focuses on delivering medicines within 15 to 30 minutes. The company intends to allocate the new funds toward enhancing its technology infrastructure, specifically aiming to refine its artificial intelligence for inventory management. The capital will also support the expansion of its pharmacy network into new locations and the strengthening of its daily operations.
The company’s operational approach centers on maintaining a large inventory compared to traditional neighborhood pharmacies. While a typical local pharmacy might hold approximately 5,000 stock-keeping units, Plazza reports that its stores stock more than 40,000 items. This inventory depth is intended to improve prescription fulfillment rates, which the company claims exceed 95%, compared to an industry average of 50% to 60%. Plazza reported a significant increase in its gross merchandise value between June 2025 and March 2026, alongside data suggesting that repeat customers tend to increase their order sizes by about 30%.
This funding occurs within an increasingly crowded Indian quick-commerce landscape. The sector is seeing aggressive expansion from established e-commerce entities, including Flipkart’s 'Flipkart Minutes' service, Zepto’s 10-minute delivery model, and Blinkit’s pilot initiatives in the pharmaceutical space.
For investors and market observers, the challenge for Plazza will be maintaining this high-inventory model while managing the costs of rapid delivery and intense competition. While the company is addressing a common issue of stock shortages at local pharmacies, the sustainability of its business model will depend on its ability to balance customer acquisition costs with efficient operational scaling. Future monitorables include the company’s ability to expand its network profitably, maintain its inventory service levels as it grows, and navigate price competition from larger, well-funded rivals entering the medicine delivery segment.